<DOC>
	<DOCNO>NCT02725736</DOCNO>
	<brief_summary>To compare tocolytic efficacy oxytocin receptor antagonist ( Atosiban ) calcium channel blocker ( Nifedipine ) among woman multiple gestation present threaten preterm labor .</brief_summary>
	<brief_title>Tocolytic Therapy Preterm Labor Multiple Gestation</brief_title>
	<detailed_description>Preterm birth remain principal cause early neonatal death . Infants born preterm ( 37 week ' gestation ) often suffer significant immediate morbidity need lengthy stay neonatal intensive care unit . Moreover , significant risk long-term neurological morbidity proportion survivor . Patients multiple gestation significant risk preterm labor delivery approximately 60 % pregnancy deliver preterm . A number oxytocin receptor antagonist develop , , three , atosiban , barusiban retosiban investigate human tocolytic agent . To date , atosiban use outside clinical trial . Atosiban oxytocin receptor antagonist specifically develop treatment preterm labor . Early report use Atosiban tocolysis show promise vitro animal study , preliminary study pregnant non-pregnant human suggest low incidence maternal side effect .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Atosiban</mesh_term>
	<mesh_term>Tocolytic Agents</mesh_term>
	<mesh_term>Vasotocin</mesh_term>
	<criteria>1 . Twin pregnancy 2 . Gestational age 24+0 32+6 week 3 . Intact amniotic membrane 4 . Threatened preterm labor 5 . Age 1850 . 1 . Rupture membranes 2 . Vaginal bleeding result placenta previa placental abruption 3 . Fever 38Â°C 4 . Severe preeclampsia 5 . Maternal cardiovascular liver diseases 6 . Systolic blood pressure le 90 mm Hg 7 . Known uterine malformation 8 . Intrauterine growth restriction fifth percentile 9 . Nonreassuring fetal status 10 . Antepartum diagnosis major fetal malformation 11 . Fetal death 12 . Previous tocolytic therapy Betamethasone treatment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>